Page
%P
-
Article
Open AccessFc receptor-like 2 (FCRL2) is a novel marker of low-risk CLL and refines prognostication based on IGHV mutation status
-
Article
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
Exome analysis of chemical-carcinogen-induced mouse tumours provides evidence for T-cell-mediated immunoselection as a mechanism of immunoediting.